Discover Astex
Our Mission & Values
Our Leadership Team
UK – Discovery Research
Jeremy Carmichael
Harren Jhoti
Michelle Jones
Neil Jones
John Lyons
Chris Murray
David Rees
Nicola Wallis
Nicola Wilsher
USA – Product Development
Mohammad Azab
Martin Buckland
Harold N. Keer
Nipun Davar
Yong Hao
Joseph Iovino
Samuel Jason
Nancy Worrell
Patti Oto
Our History
Corporate Social Responsibility
R&D
Clinical Pipeline
Proprietary Products and Programs
Guadecitabine (SGI-110) DNMT inhibitor (Hematological Malignancies and Solid Tumors)
ASTX029 Extracellular Signal-Related Protein Kinases (ERK 1/2) Inhibitor (Solid Tumors)
Oral Decitabine and Cedazuridine (ASTX727) (Hematological Malignancies)
ASTX660 Dual IAP Antagonist (Solid Tumors & Lymphomas)
Partnered Products and Programs
Kisqali
®
(ribociclib) CDK4/6 inhibitor (Oncology)
Balversa
®
(erdafitinib) FGFr inhibitor (Oncology)
AZD5363 PKB/Akt Inhibitor (Oncology)
Multiple Targets and Therapeutic Areas
Pyramid™ Discovery Platform
Oncology and CNS Discovery
Sustaining Innovation
Partnering
Our People & Culture
Career Opportunities
Media
Press Releases
Conferences & Meetings
Presentations & Publications
Interactive Scientific Resources
Interactive Software
Astex in the News
Contact
Search
Menu
Menu
You are here:
Home
1
/
Discover Astex
2
/
Our Leadership Team
3
/
USA – Product Development
4
/
Explore our scientific and clinical publications and presentations
Employment opportunities at our headquarters in UK and USA
Nicola Wilsher
Scroll to top